Eurofins Scientific Acquires Beacon Discovery

February 18, 2021

Eurofins Scientific has agreed to acquire Beacon Discovery, a San Diego–based drug discovery CRO specializing in GPCR research and compound libraries. The acquisition expands Eurofins Discovery’s integrated drug discovery capabilities, adding GPCR expertise and proprietary compound resources to support pharmaceutical and biotech clients. The transaction is expected to close in the coming weeks subject to customary conditions.

Targets
Beacon Discovery
Industry
Biotechnology
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.